Search results :

Clindamycin

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Codes: D10AF01, G01AA10, J01FF01

Side effects

Options: Show MedDRA Preferred Terms,   display all 35 labels

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Acne 34% - 100% x x x
Erythema 0.595% - 86% x x x x
Oily skin 1% - 26% x x x
Localized exfoliation 0% - 61% x x x x x x
Pruritus postmarketing, 0.595% - 60% 0% x x x x x x x x x x x x x x x x x
Vaginal moniliasis 1.5% - 13.3% 7.1% x
Application site burn 6.15% - 9.09% x
Vulvovaginal disorder 3.2% - 6.7% 7.1% x
Vulvovaginitis 4.4% - 6%
Taste bitter 5% x
Headache 0.649% - 7.06% 2.35% x x x x
Back pain 4.71% - 5% 1.18% x
Application site pruritus 1.14% - 3.25% x
Constipation 2% - 2.35% 0% x
Urinary tract infection 2% - 2.35% 0% x
Application site dryness 0.911% - 3.25% x
Vomiting 2% x x x x x x x x x x x x x
Fungal infection 1% - 1.7% 0% x
Application site reaction 0.595% - 3.1% x x
Sunburn 1.19% x x
Abnormal labour 1.1% 0.5%
Dyspnoea 1% x
Body temperature increased 1% x x
Hypotension 1% x x
Leukocytosis 1% x
Vaginal pain postmarketing, 1.9% x x
Candida infection 0.2% - 1.3% x
Trichomonal vaginitis 0% - 1.3%
Dermatitis 0% - 1.19% x
Dermatitis contact 0% - 1.19% x x x x
Fungal skin infection 0% - 1.19% x
Photosensitivity reaction 0% - 1.19% x
Abdominal pain postmarketing x x x x x x x x x x x x x x x x x x
Colitis postmarketing x x x x x x x x x x
Diarrhoea postmarketing x x x x x x x x x x x x x x x x
Dizziness postmarketing x x x
Rash postmarketing, 7% x x x x x x x x x x x x
Folliculitis postmarketing, 0% - 1.19% x x x x x x x
Haematochezia postmarketing x
Hypersensitivity postmarketing x x x x x x x x x x x
Nausea postmarketing, 2% x x x x x x x x x x x x x x x
Seborrhoeic dermatitis postmarketing x x
Urticaria postmarketing, 1% x x x x x x x x x x x
Diarrhoea haemorrhagic postmarketing x x x x x x
Vaginal discharge postmarketing x
Digestion impaired postmarketing x x x x x x
Abdominal discomfort postmarketing x x
Pain of skin postmarketing x x
Vaginal erythema postmarketing x
Application site pain postmarketing x x x
Application site rash postmarketing x x
Vaginal swelling postmarketing x
Application site erythema postmarketing x x
Pseudomembranous colitis postmarketing x x x x x x x x x x x x x
Vaginal haemorrhage postmarketing x
Abdominal cramps x
Abscess x
Agranulocytosis x x x x x x x x
Anaemia
Bacterial infection
Dermatitis exfoliative x x x x x
Dysgeusia x
Dyspepsia x
Dysuria x
Localised oedema x
Endometriosis
Eosinophilia x x x x x x x x x
Toxic epidermal necrolysis x x x x
Epistaxis
Erythema multiforme x x x x x x x x
Oesophagitis x x x x x x x x
Fatigue x
Flank pain x
Flatulence
Flushing x x
Gastrointestinal disorder
Breath odour
Cardiac arrest x
Hypertension x
Hyperthyroidism
Jaundice x x x x x x x x
Leukopenia x x x x x x x x
Measles x
Menstrual disorder x
Metrorrhagia x
Cramp muscle x
Neutropenia x x x x x x x x
Oliguria x x x x x x x x
Other acne x
Pain x x x x
Pelvic pain x
Proteinuria x x x x x x x x
Prurigo x
Pyelonephritis x
Stevens-Johnson syndrome x x x x x x x x
Superinfection x
Swelling x
Thrombocytopenia x x x x x x x x
Thrombophlebitis x x
Ulcer x
Upper respiratory tract infection
Vaginal inflammation x x x x x x x
Vertigo
Vulvitis x
Antibiotic associated colitis x
Vesiculobullous rash x x
Dry skin 0% - 12% x x x x x
Oesophageal ulcer x x x
Skin irritation x x
Polyarthritis x x x x x x x x
Fatal outcomes x
Discomfort x x
Tenderness x x
Rash erythematous 0% x
Inflammatory swelling
Burning feeling vagina x
Skin exfoliation x
Watery diarrhoea x x
Taste metallic x
Vulval erythema x
Azotaemia x x x x x x x x
Generalized aching x
Induration x
Redness x x x
Anaphylactoid reaction x x x x x x x x
Abdominal pain generalised
Stomach cramps x x x
Vaginal infection x
Skin scaly x
Rash maculo-papular x x x x
Gastrointestinal symptom NOS x
Vulvovaginal discomfort x
Vulvovaginal dryness x
Injection site irritation
Abdominal pain localised x
Pimples x
Vaginal irritation x
Cardio-respiratory arrest x
Stinging x x x
Localized erythema x
Exacerbation of acne x
Local reaction x x
Acute generalised exanthematous pustulosis x x x
Abdominal bloating x x x
Thrombophlebitis superficial x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

CLINDAMYCIN

Side effects:6
Source:FDA Structured Product Label

CLINDAMYCIN

Side effects:7
Source:FDA Structured Product Label

CLINDAMYCIN

Side effects:8
Source:FDA Structured Product Label

Clindamycin

Side effects:11
Source:FDA Structured Product Label

CLINDAMYCIN

Side effects:12
Source:FDA Structured Product Label

CLINDAMYCIN

Side effects:20
Source:FDA Structured Product Label

CLINDAMYCIN

Side effects:23
Source:FDA Structured Product Label

CLINDAMYCIN (CLINDAMYCIN PHOSPHATE) / CLINDA-T

Side effects:25
Source:Health Canada

CLINDAMYCIN

Side effects:25
Source:FDA Structured Product Label

CLINDAMYCIN (CLINDAMYCIN PHOSPHATE) / TARO-CLINDAMYCIN

Side effects:27
Source:Health Canada

CLINDAMYCIN

Side effects:27
Source:FDA Structured Product Label

CLINDAMYCIN

Side effects:28
Source:FDA Structured Product Label

CLINDAMYCIN

Side effects:29
Source:FDA Structured Product Label

CLINDAMYCIN

Side effects:30
Source:FDA Structured Product Label

CLINDAMYCIN

Side effects:41
Source:FDA Structured Product Label

CLINDAMYCIN

Side effects:45
Source:FDA Structured Product Label

Color scheme:

standardalternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label